more to come?

EY will assess veracity and accuracy of the matters highlighted by the external auditors, KPMG PLT.

Serba mgt willingness to proactively work towards resolution with latest INEDs news is commendable

huhuhu

LoL!

finishing strong to be continued tomorrow. huar arrr!

finishing strong to be continued tomorrow. huar arrr!

Good that idiots are selling off now..

ok let the idiots dump their holdings on tech company.

crapp!! anyone suicidal?

going to break ATH this week

gogogo

The Jendela digital infrastructure plan indicates that 5G rollout in the country may be deferred to 2022

hohohoho

crashed and burnt

who stucked at 930?

go go go!

GETS bends....

go go go stockraider go!

go go go stockraider go!

go go go stockraider!!!

go go go stockraider!!!!

take it easy stockraider..

Vaccine will be G2G, then MOH then GLC's Pharma....the rest makan kuci

Agreed. Covid rapid re-infection flare up is the key even given vaccine availability due to vial delivery which has to be administered by qualified and protected personnel. Glove will still prevail in the long run.

@pantor looks like there is still big gray area how the govt policy going to be implemented which I opined would strongly pivots pharma's vaccine revenue stream profitability and sustainability. I reckon govt will position it as rather strategic in seedling greater economic growth in the long run thus initial profit would be low.

whoaaaaa....profit so handsome.

Anyone have any idea how the vaccine would be applied to public once available? Is it compulsory everyone to receive jab even healthy one? how many jab suffices when there were mutation detected?

Any rough projected quarterly revenue when vaccine available?

with 6b nosh, ony 87m avg vol and most volume were traded above 6.5cent, how to push higher in short time? crazy